Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Dec;47(12):982–987. doi: 10.1136/ard.47.12.982

Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset.

A Siamopoulou-Mavridou 1, M N Manoussakis 1, A K Mavridis 1, H M Moutsopoulos 1
PMCID: PMC1003650  PMID: 3264698

Abstract

The outcomes of 419 pregnancies of 154 unselected patients with various auto-immune diseases, including 390 pregnancies before the disease onset, were studied retrospectively. The patients comprised 40 with systemic lupus erythematosus (SLE), 72 with rheumatoid arthritis, 21 with primary Sjögren's syndrome (1 degree SS), 14 with progressive systemic sclerosis (PSS), and seven with mixed connective tissue disease. The histories of 267 pregnancies of 98 healthy, age matched women served as controls. Our data indicate that compared with healthy controls autoimmune patients do not experience a higher incidence of fetal loss. The incidence of fetal loss before disease onset in the various groups of autoimmune patients (as well as after disease onset in patients with SLE and RA) was not significantly different from that of controls. Spontaneous abortions in patients with 1 degree SS and PSS before disease onset occurred significantly more frequently (p less than 0.05) than in controls. Nevertheless, it should be noted that this was not the case when the incidence per woman was considered. On the other hand, patients with SLE, both before and after disease onset, experienced a higher incidence of premature deliveries (p less than 0.05). Finally, the analysis of autoantibody profiles, including antibodies to nuclear antigens, to Ro(SSA) cellular antigen, to double stranded DNA, and to cardiolipin, could not demonstrate any association of autoantibodies with any particular pregnancy outcome.

Full text

PDF
982

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballou S. P., Morley J. J., Kushner I. Pregnancy and systemic sclerosis. Arthritis Rheum. 1984 Mar;27(3):295–298. doi: 10.1002/art.1780270308. [DOI] [PubMed] [Google Scholar]
  2. Devoe L. D., Taylor R. L. Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 1979 Oct 15;135(4):473–479. doi: 10.1016/0002-9378(79)90434-4. [DOI] [PubMed] [Google Scholar]
  3. Gimovsky M. L., Montoro M., Paul R. H. Pregnancy outcome in women with systemic lupus erythematosus. Obstet Gynecol. 1984 May;63(5):686–692. [PubMed] [Google Scholar]
  4. Harris E. N., Gharavi A. E., Hughes G. R. Anti-phospholipid antibodies. Clin Rheum Dis. 1985 Dec;11(3):591–609. [PubMed] [Google Scholar]
  5. Kaufman R. L., Kitridou R. C. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus. J Rheumatol. 1982 Jul-Aug;9(4):549–555. [PubMed] [Google Scholar]
  6. Lockshin M. D., Druzin M. L., Goei S., Qamar T., Magid M. S., Jovanovic L., Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985 Jul 18;313(3):152–156. doi: 10.1056/NEJM198507183130304. [DOI] [PubMed] [Google Scholar]
  7. Manoussakis M. N., Gharavi A. E., Drosos A. A., Kitridou R. C., Moutsopoulos H. M. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol. 1987 Sep;44(3):297–307. doi: 10.1016/0090-1229(87)90073-0. [DOI] [PubMed] [Google Scholar]
  8. Manoussakis M. N., Tzioufas A. G., Silis M. P., Pange P. J., Goudevenos J., Moutsopoulos H. M. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987 Sep;69(3):557–565. [PMC free article] [PubMed] [Google Scholar]
  9. McCune A. B., Weston W. L., Lee L. A. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med. 1987 Apr;106(4):518–523. doi: 10.7326/0003-4819-106-4-518. [DOI] [PubMed] [Google Scholar]
  10. Mintz G., Niz J., Gutierrez G., Garcia-Alonso A., Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986 Aug;13(4):732–739. [PubMed] [Google Scholar]
  11. Moutsopoulos H. M., Webber B. L., Vlagopoulos T. P., Chused T. M., Decker J. L. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979 May;66(5):733–736. doi: 10.1016/0002-9343(79)91110-0. [DOI] [PubMed] [Google Scholar]
  12. Neely N. T., Persellin R. H. Activity of rheumatoid arthritis during pregnancy. Tex Med. 1977 Aug;73(8):59–63. [PubMed] [Google Scholar]
  13. Petri M., Rheinschmidt M., Whiting-O'Keefe Q., Hellmann D., Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med. 1987 Apr;106(4):524–531. doi: 10.7326/0003-4819-106-4-524. [DOI] [PubMed] [Google Scholar]
  14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. doi: 10.1002/art.1780230510. [DOI] [PubMed] [Google Scholar]
  15. Systemic lupus erythematosus in pregnancy. Ann Intern Med. 1981 May;94(5):667–677. doi: 10.7326/0003-4819-94-5-667. [DOI] [PubMed] [Google Scholar]
  16. Tzioufas A. G., Manoussakis M. N., Drosos A. A., Silis G., Gharavi A. E., Moutsopoulos H. M. Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. Clin Exp Rheumatol. 1987 Jul-Sep;5(3):247–253. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES